The role of calprotectin in pediatric disease

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Vaos, George ^a   Kostakis, Ioannis D ^b   Zavras, Nick ^b   Chatzemichael, Athanasios ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN; MESSENGER RNA; METHOTREXATE; PROBIOTIC AGENT; CALCIUM; CARRIER PROTEIN; DIAGNOSTIC AGENT; ZINC BINDING PROTEIN; ZINC-BINDING PROTEIN;

ACUTE APPENDICITIS; CELIAC DISEASE; CHILDHOOD DISEASE; CROHN DISEASE; CYSTIC FIBROSIS; DIET THERAPY; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGLOBULIN A NEPHROPATHY; INFECTIOUS DIARRHEA; INTESTINAL FIBROSIS; JUVENILE DERMATOMYOSITIS; JUVENILE RHEUMATOID ARTHRITIS; MALARIA; MONOCYTE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NECROTIZING ENTEROCOLITIS; NEUROBLASTOMA CELL; PATHOGENESIS; POLYMYOSITIS; PROTEIN FUNCTION; REVIEW; ULCERATIVE COLITIS; CHILD; CLASSIFICATION; GENETICS; INFLAMMATION; METABOLISM; NEUTROPHIL; PATHOLOGY; PEDIATRICS; PRESCHOOL CHILD;

CALCIUM; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; HUMANS; INFLAMMATION; LEUKOCYTE L1 ANTIGEN COMPLEX; NEUTROPHILS; PEDIATRICS;

EID: 84885598984     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/542363     Document Type: Review

References (85)

1. Yui S., Nakatani Y., Mikami M., Calprotectin (S100A8/S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity. Biological and Pharmaceutical Bulletin 2003 26 6 753 760 2-s2.0-0347726938 (Pubitemid 39655290)
2. Stříž I., Trebichavský I., Calprotectin-a pleiotropic molecule in acute and chronic inflammation. Physiological Research 2004 53 3 245 253 2-s2.0-2942748480 (Pubitemid 38797280)
3. Stroncek D. F., Shankar R. A., Skubitz K. M., The subcellular distribution of myeloid-related protein 8 (MRP8) and MRP14 in human neutrophils. Journal of Translational Medicine 2005 3, article 36 2-s2.0-27344442276 10.1186/1479-5876-3-36 (Pubitemid 41522376)
4. Rodrigo L., Fecal calprotectin. Revista Espanola de Enfermedades Digestivas 2007 99 12 683 688 2-s2.0-40949164270 (Pubitemid 351416314)
5. McNutt N. S., The S100 family of multipurpose calcium-binding proteins. Journal of Cutaneous Pathology 1998 25 10 521 529 2-s2.0-0031744189 (Pubitemid 28552506)
6. Tibble J. A., Bjarnason I., Non-invasive investigation of inflammatory bowel disease. World Journal of Gastroenterology 2001 7 4 460 465 2-s2.0-0034868442 (Pubitemid 32782620)
7. Passey R. J., Xu K., Hume D. A., Geczy C. L., S100A8: emerging functions and regulation. Journal of Leukocyte Biology 1999 66 4 549 556 2-s2.0-0032831636 (Pubitemid 29489878)
8. Viemann D., Barczyk K., Vogl T., Fischer U., Sunderkötter C., Schulze-Osthoff K., Roth J., MRP8/MRP14 impairs endothelial integrity and induces a caspase-dependent and -independent cell death program. Blood 2007 109 6 2453 2460 2-s2.0-33947272221 10.1182/blood-2006-08-040444 (Pubitemid 46425888)
9. Ahmad A., Bayley D. L., He S., Stockley R. A., Myeloid related protein-8/14 stimulates interleukin-8 production in airway epithelial cells. American Journal of Respiratory Cell and Molecular Biology 2003 29 4 523 530 2-s2.0-0141749139 10.1165/rcmb.2002-0286OC (Pubitemid 37222691)
10. Viemann D., Strey A., Janning A., Jurk K., Klimmek K., Vogl T., Hirono K., Ichida F., Foell D., Kehrel B., Gerke V., Sorg C., Roth J., Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells. Blood 2005 105 7 2955 2962 2-s2.0-19944417730 10.1182/blood-2004-07-2520 (Pubitemid 40446292)
11. Sunahori K., Yamamura M., Yamana J., Takasugi K., Kawashima M., Yamamoto H., Chazin W. J., Nakatani Y., Yui S., Makino H., The S100A8/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen-activated protein kinase in rheumatoid arthritis. Arthritis Research and Therapy 2006 8 3, article no. R69 2-s2.0-34548036986 10.1186/ar1939
12. Nacken W., Roth J., Sorg C., Kerkhoff C., S100A9/S100A8: myeloid representatives of the S100 protein family as prominent players in innate immunity. Microscopy Research and Technique 2003 60 6 569 580 2-s2.0-0242335600
13. Bunn S. K., Bisset W. M., Main M. J. C., Golden B. E., Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition 2001 32 2 171 177 2-s2.0-0035065788 10.1097/00005176-200102000-00015 (Pubitemid 32280632)
14. Ashorn S., Honkanen T., Kolho K.-L., Ashorn M., Välineva T., Wei B., Braun J., Rantala I., Luukkaala T., Iltanen S., Fecal calprotectin levels and serological responses to microbial antigens among children and adolescents with inflammatory bowel disease. Inflammatory Bowel Diseases 2009 15 2 199 205 2-s2.0-66049137260 10.1002/ibd.20535
15. Kolho K.-L., Turner D., Veereman-Wauters G., Sladek M., de Ridder L., Shaoul R., Paerregaard A., Amil Dias J. A., Koletzko S., Nuti F., Bujanover Y., Staiano A., Bochenek K., Finnby L., Levine A., Veres G., Rapid test for fecal calprotectin levels in children with Crohn's disease. Journal of Pediatric Gastroenterology and Nutrition 2012 55 4 436 439 2-s2.0-84857965245 10.1097/MPG.0b013e318253cff1
16. Kostakis I. D., Cholidou K. G., Vaiopoulos A. G., Vlachos I. S., Perrea D., Vaos G., Fecal calprotectin in pediatric Inflammatory bowel disease: a systematic review. Digestive Diseases and Sciences 2013 58 2 309 319
17. Komraus M., Wos H., Wiecek S., Kajor M., Grzybowska-Chlebowczyck U., Usefulness of feacal calprotectin measurement in children with various types of inflammatory bowel disease. Mediators of Inflammation 2012 2012 5 608249 10.1155/2012/608249
18. Leach S. T., Yang Z., Messina I., Song C., Geczy C. L., Cunningham A. M., Day A. S., Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2007 42 11 1321 1331 2-s2.0-35148869758 10.1080/00365520701416709 (Pubitemid 47537067)
19. Fagerberg U. L., Lööf L., Myrdal U., Hansson L.-O., Finkel Y., Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms. Journal of Pediatric Gastroenterology and Nutrition 2005 40 4 450 455 2-s2.0-16844377257 10.1097/01.MPG.0000154657.08994.94 (Pubitemid 40489572)
20. Bremner A., Roked S., Robinson R., Phillips I., Beattie M., Faecal calprotectin in children with chronic gastrointestinal symptoms. Acta Paediatrica 2005 94 12 1855 1858 2-s2.0-31544450583 10.1080/08035250500254639 (Pubitemid 43155608)
21. Joishy M., Davies I., Ahmed M., Wassel J., Davies K., Sayers A., Jenkins H., Fecal calprotectin and lactoferrin as noninvasive markers of pediatric inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition 2009 48 1 48 54 2-s2.0-63649103959 10.1097/MPG.0b013e31816533d3
22. Quail M. A., Russell R. K., van Limbergen J. E., Rogers P., Drummond H. E., Wilson D. C., Gillett P. M., Fecal calprotectin complements routine laboratory investigations in diagnosing childhood inflammatory bowel disease. Inflammatory Bowel Diseases 2009 15 5 756 759 2-s2.0-67650289790 10.1002/ibd.20820
23. Diamanti A., Colistro F., Basso M. S., Papadatou B., Francalanci P., Bracci F., Muraca M., Knafelz D., de Angelis P., Castro M., Clinical role of calprotectin assay in determining histological relapses in children affected by inflammatory bowel diseases. Inflammatory Bowel Diseases 2008 14 9 1229 1235 2-s2.0-54349085591 10.1002/ibd.20472
24. Berni Canani R., Terrin G., Rapacciuolo L., Miele E., Siani M. C., Puzone C., Cosenza L., Staiano A., Troncone R., Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease. Digestive and Liver Disease 2008 40 7 547 553 2-s2.0-44949220187 10.1016/j.dld.2008.01.017
25. Walkiewicz D., Werlin S. L., Fish D., Scanlon M., Hanaway P., Kugathasan S., Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease. Inflammatory Bowel Diseases 2008 14 5 669 673 2-s2.0-44349168884 10.1002/ibd.20376 (Pubitemid 351742984)
26. Bunn S. K., Bisset W. M., Main M. J. C., Gray E. S., Olson S., Golden B. E., Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition 2001 33 1 14 22 2-s2.0-0034906225 10.1097/00005176-200107000-00003 (Pubitemid 32706118)
27. van Rheenen P. F., Role of fecal calprotectin testing to predict relapse in teenagers with inflammatory bowel disease who report full disease control. Inflammatory Bowel Diseases 2012 18 11 2018 2025 2-s2.0-84856094393 10.1002/ibd.22896
28. Fagerberg U. L., Lööf L., Lindholm J., Hansson L.-O., Finkel Y., Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition 2007 45 4 414 420 2-s2.0-37349120717 10.1097/MPG.0b013e31810e75a9 (Pubitemid 350307158)
29. Canani R. B., de Horatio L. T., Terrin G., Romano M. T., Miele E., Staiano A., Rapacciuolo L., Polito G., Bisesti V., Manguso F., Vallone G., Sodano A., Troncone R., Combined use of noninvasive tests is useful in the initial diagnostic approach to a child with suspected inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition 2006 42 1 9 15 2-s2.0-30344473317 10.1097/01.mpg.0000187818.76954.9a (Pubitemid 43061003)
30. Henderson P., Casey A., Lawrence S. J., Kennedy N. A., Kingstone K., Rogers P., Gillett P. M., Wilson D. C., The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease. American Journal of Gastroenterology 2012 2-s2.0-84857418738 10.1038/ajg.2012.33
31. Konikoff M. R., Denson L. A., Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease. Inflammatory Bowel Diseases 2006 12 6 524 534 2-s2.0-33745262396 10.1097/00054725-200606000-00013
32. van Rheenen P. F., van de Vijver E., Fidler V., Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. British Medical Journal 2010 341, article c3369 2-s2.0-77954964440 10.1136/bmj.c3369
33. van de Vijver E., Schrender A. B., Cnossen W. R., Safety ruling out inflammatory bowel disease in children and teenagers without referral for endoscopy. Archives of Disease in Childhood 2012 97 12 1014 1018
34. Canani R. B., Rapacciuolo L., Romano M. T., De Horatio L. T., Terrin G., Manguso F., Cirillo P., Paparo F., Troncone R., Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice. Digestive and Liver Disease 2004 36 7 467 470 2-s2.0-4444320724 10.1016/j.dld.2004.02.009 (Pubitemid 41115450)
35. Shulman R. J., Eakin M. N., Czyzewski D. I., Jarrett M., Ou C.-N., Increased gastrointestinal permeability and gut inflammation in children with functional abdominal pain and irritable bowel syndrome. Journal of Pediatrics 2008 153 5 646 650 2-s2.0-55549142198 10.1016/j.jpeds.2008.04.062
36. Kolho K.-L., Raivio T., Lindahl H., Savilahti E., Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2006 41 6 720 725 2-s2.0-33745714449 10.1080/00365520500419623 (Pubitemid 43995015)
37. Navas López V. M., Blasco Alonso J., Sierra Salinas C., Barco Gálvez A., Vicioso Recio M. I., Efficacy of exclusive enteral feeding as primary therapy for paediatric Crohn's disease. Anales de Pediatria 2008 69 6 506 514 2-s2.0-59749089143 10.1016/S1695-4033(08)75232-9
38. Baldassarre M. E., Laforgia N., Fanelli M., Laneve A., Grosso R., Lifschitz C., Lactobacillus GG improves recovery in infants with blood in the stools and presumptive allergic colitis compared with extensively hydrolyzed formula alone. Journal of Pediatrics 2010 156 3 397 401 2-s2.0-76749157081 10.1016/j.jpeds.2009.09.012
39. Hämäläinen A., Sipponen T., Kolho K.-L., Infliximab in pediatric inflammatory bowel disease rapidly decreases fecal calprotectin levels. World Journal of Gastroenterology 2011 17 47 5166 5171 2-s2.0-83755194964 10.3748/wjg.v17.i47.5166
40. Kapel N., Roman C., Caldari D., Sieprath F., Canioni D., Khalfoun Y., Goulet O., Ruemmele F. M., Fecal tumor necrosis factor- α and calprotectin as differential diagnostic markers for severe diarrhea of small infants. Journal of Pediatric Gastroenterology and Nutrition 2005 41 4 396 400 2-s2.0-26044454839 10.1097/01.mpg.0000178437.87546.06 (Pubitemid 41407599)
41. Chen C. C., Huang J. L., Chang C. J., Kong M. S., Fecal calprotectin as a correlative marker in clinical severity of infectious diarrhea and usefulness in evaluating bacterial or viral pathogens in children., Journal of Pediatric Gastroenterology and Nutrition 2012 55 5 541 547
42. Carroccio A., Iacono G., Cottone M., Di Prima L., Cartabellotta F., Cavataio F., Scalici C., Montalto G., Di Fede G., Rini G., Notarbartolo A., Averna M. R., Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: a prospective study in adults and children. Clinical Chemistry 2003 49 6, part 1 861 867 2-s2.0-0038359391 10.1373/49.6.861 (Pubitemid 36623463)
43. Stoll M. L., Patel A. S., Punaro M., Fecal calprotectin in children with the enthesitis-related arthritis subtype of juvenile idiopathic arthritis. Journal of Rheumatology 2011 38 10 2274 2275 2-s2.0-80053521383 10.3899/jrheum.110508
44. Yang Q., Smith P. B., Goldberg R. N., Cotten C. M., Dynamic change of fecal calprotectin in very low birth weight infants during the first month of life. Neonatology 2008 94 4 267 271 2-s2.0-51249094899 10.1159/000151645
45. Carroll D., Corfield A., Spicer R., Cairns P., Faecal calprotectin concentrations and diagnosis of necrotising enterocolitis. The Lancet 2003 361 9354 310 311 2-s2.0-0037464755 10.1016/S0140-6736(03)12333-1 (Pubitemid 36126194)
46. Aydemir G., Kekmez F., Yanju I. A., Increased fecal calprotecitn in preterm infants with necrotizing enterocolitis. Clinical Laboratory 2012 58 841 844
47. Reisinger K. W., van der Zee D. C., Brouwers H. A., Non-invasive measurement of calprotectin and serum amyloid a combined with intestinal fatty acid-binding protein in necrotizing enterocolitis. Journal of Pediatric Surgery 2012 47 9 1640 1645
48. Selimoglu M. A., Temel I., Yildirim Ç., Özyalin F., Aktaş M., Karabiber H., The role of fecal calprotectin and lactoferrin in the diagnosis of necrotizing enterocolitis. Pediatric Critical Care Medicine 2011 13 4 452 454 2-s2.0-80855145409 10.1097/PCC.0b013e3182388ae9
49. Balamtekin N., Demir M., Baysoy G., Fecal calprotectin concentration is increased in children with celiac diseases: relation with histopathological findings. Turkish Journal of Gastroenterology 2012 23 5 503 508
50. Ertekin V., Selimoglu M. A., Turgut A., Bakan N., Fecal calprotectin concentration in celiac disease. Journal of Clinical Gastroenterology 2010 44 8 544 546 2-s2.0-77955931612 10.1097/MCG.0b013e3181cadbc0
51. Bruzzese E., Raia V., Gaudiello G., Polito G., Buccigrossi V., Formicola V., Guarino A., Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration. Alimentary Pharmacology and Therapeutics 2004 20 7 813 819 2-s2.0-4844226186 10.1111/j.1365-2036.2004.02174. x (Pubitemid 39319237)
52. Lee J. M., Leach S. T., Katz T., Day A. S., Jaffe A., Ooi C. Y., Update of faecal markers of inflammation in children with cystic fibrosis. Mediators of Inflammation 2012 2012 6 948367 10.1155/2012/948367
53. Hestvik E., Ollafstottir E., Tylleskar T., Fecal calprotectin in HIV-infected, HAAR-naïve Ugandan children. Journal of Pediatric Gastroenterology and Nutrition 2012 54 6 785 790
54. Terrin G., Passariello A., Curtis M. D., Paludetto R., Canani R. B., S100A8/A9 protein is a marker for early diagnosis of necrotizing enterocolitis in neonates. Archives of Disease in Childhood 2012 97 12 1102
55. Frosch M., Ahlmann M., Vogl T., Wittkowski H., Wulffraat N., Foell D., Roth J., The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1 β form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis. Arthritis and Rheumatism 2009 60 3 883 891 2-s2.0-61749104104 10.1002/art.24349
56. Schulze zur Wiesch A., Foell D., Frosch M., Vogl T., Sorg C., Roth J., Myeloid related proteins MRP8/MRP14 may predict disease flares in juvenile idiopathic arthritis. Clinical and Experimental Rheumatology 2004 22 3 368 373 2-s2.0-2342506553 (Pubitemid 38585243)
57. Gerss J., Roth J., Holzinger D., Phagocyte-specific S100 proteins and high-sensitivity C reactive protein as biomarkers for a nik-adapted treatment to maintain remission in juvenile idiopathic arthritis: a comparative study. Annals of the Rheumatic Diseases 2012 71 12 1991 1997
58. Foell D., Frosch M., Schulze zur Wiesch A., Vogl T., Sorg C., Roth J., Methotrexate treatment in juvenile idiopathic arthritis: when is the right time to stop? Annals of the Rheumatic Diseases 2004 63 2 206 208 2-s2.0-1642580540 10.1136/ard.2003.005686 (Pubitemid 38122142)
59. Frosch M., Metze D., Foell D., Vogl T., Sorg C., Sunderkötter C., Roth J., Early activation of cutaneous vessels and epithelial cells is characteristic of acute systemic onset juvenile idiopathic arthritis. Experimental Dermatology 2005 14 4 259 265 2-s2.0-16844382496 10.1111/j.0906-6705.2005.00271.x (Pubitemid 40485453)
60. Wulffraat N. M., Haas P. J., Frosch M., de Kleer I. M., Vogl T., Brinkman D. M. C., Quartier P., Roth J., Kuis W., Myeloid related protein 8 and 14 secretion reflects phagocyte activation and correlates with disease activity in juvenile idiopathic arthritis treated with autologous stem cell transplantation. Annals of the Rheumatic Diseases 2003 62 3 236 241 2-s2.0-0037369377 10.1136/ard.62.3.236 (Pubitemid 36238087)
61. Hirono K., Foell D., Xing Y., Miyagawa-Tomita S., Ye F., Ahlmann M., Vogl T., Futatani T., Rui C., Yu X., Watanabe K., Wanatabe S., Tsubata S., Uese K., Hashimoto I., Ichida F., Nakazawa M., Roth J., Miyawaki T., Expression of Myeloid-Related Protein-8 and -14 in Patients With Acute Kawasaki Disease. Journal of the American College of Cardiology 2006 48 6 1257 1264 2-s2.0-33748437572 10.1016/j.jacc.2006.02.077 (Pubitemid 44345126)
62. Abe J., Jibiki T., Noma S., Nakajima T., Saito H., Terai M., Gene expression profiling of the effect of high-dose intravenous Ig in patients with Kawasaki disease. Journal of Immunology 2005 174 9 5837 5845 2-s2.0-17844372520 (Pubitemid 40593229)
63. Guggino G., Cimaz R., Accamndo S., Increased percentages of tumor necrosis factor-alpha+/interferon-gamma +T[corrected] lymphocytes and calprotectin+/tumor necrosis factor-alpha+monocytes in patients with acute Kawasaki disease. International Journal of Immunopathology and Pharmacology 2012 25 1 99 105
64. Aoki T., Matsumoto Y., Hirata K., Ochiai K., Okada M., Ichikawa K., Shibasaki M., Arinami T., Sumazaki R., Noguchi E., Expression profiling of genes related to asthma exacerbations. Clinical and Experimental Allergy 2009 39 2 213 221 2-s2.0-58849125851 10.1111/j.1365-2222.2008.03186.x
65. Renaud W., Merten M., Figarella C., Increased coexpression of CFTR and S100 calcium binding proteins MRP8 and MRP14 mRNAs in cystic fibrosis human tracheal gland cells. Biochemical and Biophysical Research Communications 1994 201 3 1518 1525 2-s2.0-0027999172 10.1006/bbrc.1994.1876
66. Golden B. E., Clohessy P. A., Russell G., Fagerhol M. K., Calprotectin as a marker of inflammation in cystic fibrosis. Archives of Disease in Childhood 1996 74 2 136 139 2-s2.0-0030020437 (Pubitemid 26057695)
67. Kumar R. K., Yang Z., Bilson S., Thliveris S., Cooke B. E., Geczy C. L., Dimeric S100A8 in human neutrophils is diminished after phagocytosis. Journal of Leukocyte Biology 2001 70 1 59 64 2-s2.0-0034973301 (Pubitemid 32613663)
68. Bealer J. F., Colgin M., S100A8/A9: a potential new diagnostic aid for acute appendicitis. Academic Emergency Medicine 2010 17 3 333 336 2-s2.0-77951124844 10.1111/j.1553-2712.2010.00663.x
69. Thuijls G., Derikx J. P., Prakken F. J., Huisman B., van Bijnen Ing A. A., van Heurn E. L. W. E., Buurman W. A., Heineman E., A pilot study on potential new plasma markers for diagnosis of acute appendicitis. American Journal of Emergency Medicine 2011 29 3 256 260 2-s2.0-79951893591 10.1016/j.ajem.2009.09.029
70. Kharbanda A. B., Rai A. J., Cosme Y., Liu K., Dayan P. S., Novel serum and urine markers for pediatric appendicitis. Academic Emergency Medicine 2012 19 1 56 62 2-s2.0-84856006035 10.1111/j.1553-2712.2011.01251.x
71. BET 3: super calprotectin will not expedite your discharge. Emergency Medical Journal 2013 30 8 691 693
72. Sampson B., Fagerhol M. K., Sunderkötter C., Golden B. E., Richmond P., Klein N., Kovar I. Z., Beattie J. H., Wolska-Kusnierz B., Saito Y., Roth J., Hyperzincaemia and hypercalprotectinaemia: a new disorder of zinc metabolism. The Lancet 2002 360 9347 1742 1745 2-s2.0-0037202853 10.1016/S0140-6736(02) 11683-7 (Pubitemid 35447905)
73. Saito Y., Saito K., Hirano Y., Ikeya K., Suzuki H., Shishikura K., Manno S., Takakuwa Y., Nakagawa K., Iwasa A., Fujikawa S., Moriya M., Mizoguchi N., Golden B. E., Osawa M., Hyperzincemia with systemic inflammation: a heritable disorder of calprotectin metabolism with rheumatic manifestations? Journal of Pediatrics 2002 140 2 267 269 2-s2.0-0036191648 10.1067/mpd.2002.121699 (Pubitemid 34183674)
74. Fessatou S., Fagerhol M. K., Roth J., Stamoulakatou A., Kitra V., Hadarean M., Paleologos G., Chandrinou H., Sampson B., Papassotiriou I., Severe anemia and neutropenia associated with hyperzincemia and hypercalprotectinemia. Journal of Pediatric Hematology/Oncology 2005 27 9 477 480 2-s2.0-25844475884 10.1097/01.mph.0000179958.19524.9c (Pubitemid 41395900)
75. Sugiura T., Goto K., Ito K., Ban K., Okada S., Moriyama A., Togari H., Effects of cyclosporine A in hyperzincaemia and hypercalprotectinaemia. Acta Paediatrica 2006 95 7 857 860 2-s2.0-33747626745 10.1080/08035250500482255 (Pubitemid 44261747)
76. Isidor B., Poignant S., Corradini N., Fouassier M., Quartier P., Roth J., Picherot G., Hyperzincemia and hypercalprotectinemia: unsuccessful treatment with tacrolimus. Acta Paediatrica 2009 98 2 410 412 2-s2.0-58449101879 10.1111/j.1651-2227.2008.01092.x
77. Lionetti G., Bernstein J. A., Holzinger D., IL-1 blockade as a novel approach to treatment of hyperzicemia and hypercalprotectinemia, a possible new autoinflammatory syndrome. Pediatric Rheumatology 2012 10 supplement 1, article A87
78. Bordmann G., Burmeister G., Saladin S., Urassa H., Mwankyusye S., Weiss N., Tanner M., MRP 8/14 as marker for Plasmodium falciparum -induced malaria episodes in individuals in a holoendemic area. Clinical and Diagnostic Laboratory Immunology 1997 4 4 435 439 2-s2.0-0030860146 (Pubitemid 27321776)
79. Frosch M., Vogl T., Waldherr R., Sorg C., Sunderkötter C., Roth J., Expression of MRP8 and MRP14 by macrophages is a marker for severe forms of glomerulonephritis. Journal of Leukocyte Biology 2004 75 2 198 206 2-s2.0-0842266782 10.1189/jlb.0203076 (Pubitemid 38174575)
80. Kawasaki Y., Hosoya M., Takahashi A., Isome M., Tanji M., Suzuki H., Myeloid-related protein 8 expression on macrophages is a useful prognostic marker for renal dysfunction in children with MPGN type 1. American Journal of Kidney Diseases 2005 45 3 510 518 2-s2.0-14844296975 10.1053/j.ajkd.2004.11.019 (Pubitemid 40341330)
81. Kawasaki Y., Suyama K., Go H., Imamura T., Ushijima Y., Sakai N., Hashimoto K., Hosoya M., Accumulation of macrophages expressing myeloid-related protein 8 associated with the progression of sclerotic changes in children with IgA nephropathy. Tohoku Journal of Experimental Medicine 2009 218 1 49 55 2-s2.0-69249088057 10.1620/tjem.218.49
82. Rostasy K. M., Piepkorn M., Goebel H.-H., Menck S., Hanefeld F., Schulz-Schaeffer W. J., Monocyte/macrophage differentiation in dermatomyositis and polymyositis. Muscle and Nerve 2004 30 2 225 230 2-s2.0-3242780081 10.1002/mus.20088 (Pubitemid 38982227)
83. Ehrchen J. M., Sunderkötter C., Foell D., Vogl T., Roth J., The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. Journal of Leukocyte Biology 2009 86 3 557 566 2-s2.0-67649208478 10.1189/jlb.1008647
84. Gebhardt C., Németh J., Angel P., Hess J., S100A8 and S100A9 in inflammation and cancer. Biochemical Pharmacology 2006 72 11 1622 1631 2-s2.0-33750505883 10.1016/j.bcp.2006.05.017 (Pubitemid 44666730)
85. Morandi F., Scaruffi P., Gallo F., Stigliani S., Moretti S., Bonassi S., Gambini C., Mazzocco K., Fardin P., Haupt R., Arcamone G., Pistoia V., Tonini G. P., Corrias M. V., Bone marrow-infiltrating human neuroblastoma cells express high levels of calprotectin and HLA-g proteins. PLoS ONE 2012 7 1 2-s2.0-84855506127 10.1371/journal.pone.0029922 e29922